Impact of early steroid withdrawal on progression of interstitial fibrosis and tubular atrophy after kidney transplantation

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Introduction : Long-term effects of early steroid withdrawal (ESW) on development of chronic histopathology changes in kidney allograft are unclear. Methods : We compared chronic pathohistology scores on protocol biopsies in kidney recipients (N = 124) without delayed graft function with ESW (79) vs. continuous steroids (45) on top of calcineurin inhibitor and mycophenolate mofetil. Induction immunosuppression consisted of interleukin 2 receptor antibodies (IL-2R). Protocol biopsies were done at implantation and 1-year after transplantation. Chronic scores (ci, ct, cg, mm, cv and ah) were analyzed by the Banff 97 classification and it updates. Results : 1-year progression of interstitial fibrosis was similar in ESW versus continuous steroids group (0.52 ± 0.62 vs. 0.69 ± 0.76, p = 0.28). Similarly, progression of tubular atrophy was not different in ESW versus continuous steroids group (0.58 ± 0.67 vs. 0.76 ± 0.71, p = 0.17). There was not statistically different progression in any histopathology score between groups of immunosuppression on steroids or ESW. Kidney function was also similar at 3, 6 and 12 months between the ESW and steroid group. Conclusion : In conclusion, ESW does not have negative impact on progression of interstitial fibrosis and tubular atrophy. Kidney function was comparable between ESW and continuous steroids group on 3, 6 and 12 months after kidney transplantation.

Article activity feed